Growth Metrics

Oruka Therapeutics (ORKA) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.13%
Dec 31, 2025 -3.05%
Sep 30, 2025 41.66%
Jun 30, 2025 -5.78%
Mar 31, 2025 -4.58%
Dec 31, 2024 11.64%
Sep 30, 2024 1,281.35%
Jun 30, 2024 -310.55%
Mar 31, 2024 -119.07%
Dec 31, 2023 -2.50%
Sep 30, 2023 -3.24%
Jun 30, 2023 -3.19%
Mar 31, 2023 -2.74%
Dec 31, 2022 -2.47%
Sep 30, 2022 -4.97%
Jun 30, 2022 -6.21%
Mar 31, 2022 -6.08%
Dec 31, 2021 -9.82%
Sep 30, 2021 -7.53%
Jun 30, 2021 -7.13%
Mar 31, 2021 41.68%
Dec 31, 2020 -7.80%
Sep 30, 2020 389.62%
Jun 30, 2020 63.42%
Mar 31, 2020 -17.14%
Dec 31, 2019 -13.51%
Sep 30, 2019 -4.24%
Jun 30, 2019 25.57%
Mar 31, 2019 21.32%
Dec 31, 2018 -19.17%
Sep 30, 2018 -17.06%
Jun 30, 2018 -18.60%
Mar 31, 2018 7.58%
Dec 31, 2017 -28.41%
Sep 30, 2017 -2.68%
Jun 30, 2017 -18.24%
Mar 31, 2017 -18.73%
Dec 31, 2016 -16.19%
Sep 30, 2016 -14.28%
Jun 30, 2016 -10.68%
Mar 31, 2016 -9.16%
Dec 31, 2015 -7.36%
Sep 30, 2015 -6.09%
Jun 30, 2015 260.83%
Mar 31, 2015 -17.73%
Dec 31, 2014 -14.29%
Sep 30, 2014 -10.99%
Jun 30, 2014 -10.28%
Mar 31, 2014 38.21%
Dec 31, 2013 -15.18%
Sep 30, 2013 -8.31%
Jun 30, 2013 505.04%
Mar 31, 2013 13.90%
Dec 31, 2012 -8.47%
Sep 30, 2012 -3.38%
Jun 30, 2012 -24.54%
Mar 31, 2012 -24.01%
Dec 31, 2011 0.00%
Sep 30, 2011 -24.03%